Clinical and research tests for C1836544 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 51

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Lysosomal Storage Disease Panel Molecular Genetics Laboratory London Health Sciences Centre Canada	77	50	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region
CentoMetabolic MOx Centogene US, LLC - The Rare Disease Company United States	195	221	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoXome MOx (Whole Exome Sequencing) Centogene US, LLC - The Rare Disease Company United States	13	20	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region U Uniparental disomy study (UPD)
CentoLSD Centogene US, LLC - The Rare Disease Company United States	12	18	A Analyte
CentoLSD MOx Centogene US, LLC - The Rare Disease Company United States	12	37	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoICU Panel Centogene US, LLC - The Rare Disease Company United States	829	848	C Sequence analysis of the entire coding region
CentoIEM Panel Centogene US, LLC - The Rare Disease Company United States	669	688	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoNeuro Panel Centogene US, LLC - The Rare Disease Company United States	1886	1858	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Epilepsy Panel Centogene US, LLC - The Rare Disease Company United States	734	744	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Intellectual Disability Panel Centogene US, LLC - The Rare Disease Company United States	777	770	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
NAGA - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoSphingo MOx Centogene US, LLC - The Rare Disease Company United States	10	20	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoSphingo Centogene US, LLC - The Rare Disease Company United States	10	10	A Analyte
CentoMetabolic MOx Centogene AG - the Rare Disease Company Germany	195	221	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoXome MOx (Whole Exome Sequencing) Centogene AG - the Rare Disease Company Germany	13	19	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region U Uniparental disomy study (UPD)
CentoLSD Centogene AG - the Rare Disease Company Germany	12	18	A Analyte
CentoLSD MOx Centogene AG - the Rare Disease Company Germany	12	36	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoSphingo Centogene AG - the Rare Disease Company Germany	10	10	A Analyte
CentoSphingo MOx Centogene AG - the Rare Disease Company Germany	10	20	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
NAGA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 51

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.